An open-label clinical trial of agalsidase alfa enzyme replacement therapy in children with Fabry disease who are naïve to enzyme replacement therapy

Overview of attention for article published in Drug Design, Development and Therapy, May 2016

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 16 Dimensions

Readers on

mendeley: 82 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 34 followers.

Agalsidase alfa in children with Fabry disease naive to ERT https://t.co/dJ36t1zG3e

Reply Repost Favourite